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Supplementary File 1: Warwick visceral leishmaniasis transmission
model
1. Model structure
As described in the main text, the structure of the model is similar to that of Stauch et al [21, 22]. The key differ-
ences are that dormant infection (following asymptomatic infection or treatment for clinical VL) and PKDL are not
modelled; there are fewer compartments for asymptomatically infected and recovered individuals; and symptomatic
infection is split into one or more sub-compartments depending on the distribution of onset-to-treatment times in the
district being modelled. We choose not to model dormant infection and PKDL due to uncertainty in the information
on PKDL in the data (information on clinical VL and PKDL history was not segregated for individuals with PKDL)
and over what proportion of individuals with PKDL were actually diagnosed (as some may not have sought treatment
or had clinical VL prior to PKDL). According to the data only 2.5% of individuals treated for VL developed PKDL,
which, if representative of the actual PKDL incidence, suggests that PKDL cases were probably not a major source of
transmission during the study period. The other two differences mentioned above reflect the fact that the data does not
include any information on asymptomatic infection/recovery from diagnostics, unlike the KalaNet data to which the
Stauch model and Erasmus models were fitted, but does contain detailed information on patients’ onset-to-treatment
times. A schematic of the model structure, including the multiple compartments for symptomatic infection, is shown
in Figure S1. The notation used is as follows: S stands for susceptible, E for latently infected, I for infectious, A
for asymptomatically infected, K for symptomatically infected (kala-azar (KA)), T1 for first-line treatment, T2 for
second-line treatment, R for recovered. Subscripts V denote stages of sandly infection. All model parameters are
listed in Table S1 with their definitions and values.
2. Model equations
The system of ordinary differential equations (ODEs) that constitute the transmission model are given below.
Given the relatively short time period covered by the data and the unknown relationship between the human and
sandfly population sizes, we assume that the human population, N, is constant and the mean sandfly-to-human ratio
(SHR) (averaged over seasonal variation), nV (t) = NV (t)/N, is constant in the absence of vector control.
The equations for the different human infection stages, in terms of proportions of the total human population, with
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Figure S1. Flow diagram of model structure with 2 sub-compartments for symptomatic infection. Model parameters defined in Table S1 and §2.
2 sub-compartments for symptomatic infection, are:
dS
dt
= α − (λH + µ)S + κR, (1)
dA
dt
= λHS − (γ + µ)A, (2)
dK1
dt
= f1γA − (2δ + µ1)K1, (3)
dK2
dt
= 2δK1 − (2δ + µ1)K2, (4)
dT1
dt
= 2δK2 − (τ + µ2)T1, (5)
dT2
dt
= f2τT1 − (τ + µ2)T2, (6)
dR
dt
= (1 − f1)γA + (1 − f2)τT1 + τT2 − (κ + µ)R. (7)
where all parameters are as defined in Table S1; µ1 = µ+µK ; µ2 = µ+µK +µT ; α = µ+µK(K1 +K2)+(µK +µT )(T1 +T2)
is the birth rate, such that the birth rate balances the net death rate (the natural death rate plus excess mortality due to
VL and treatment); and λH = βpHnV IV is the force of infection from sandflies towards humans (assuming frequency-
dependent transmission, as is the norm for vector-borne diseases). Following [14], the number of sub-compartments
for symptomatic infection for each district is determined by fitting an Erlang distribution (a gamma distribution with
positive integer shape parameter m ∈ Z+), to the distribution of onset-to-treatment times for that district by maximum
likelihood estimation. In other words, a probability density function of the form
f (t; m,mδ) =
(mδ)mtm−1 exp(−mδt)
(m − 1)! ,
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is fitted to the onset-to-treatment time distribution for each district, where m is the number of sub-compartments and
1/δ is the mean waiting time (so mδ is the rate parameter for progression to the next sub-compartment). Above the
system is given for m = 2. With m = 1 (1 compartment for symptomatic infection), equations (3)–(5) are replaced by
dK1
dt
= f1γA − (δ + µ1)K1, (8)
dT1
dt
= δK1 − (τ + µ2)T1, (9)
and α = µ + µK K1 + (µK + µT )(T1 + T2). Figure S2 shows the distributions of onset-to-treatment times in 2012 for
each district with the fitted Erlang distributions, and Table S3 gives the means and standard deviations of the fitted
distributions for 2012 and 2013. The distributions vary considerably between districts, with fitted means and standard
deviations ranging from 21.5 days for Begusarai to 63.6 days for W. Champaran in 2012. The best-fit distributions
were Erlang distributions with m = 2 (2 KA sub-compartments) for Saharsa, E. Champaran, Samastipur, Khagaria, and
Patna, and exponential distributions (m = 1, i.e. 1 KA compartment) for Gopalganj, Begusarai, and W. Champaran.
Equations (1)–(7) are supplemented by an equation for the cumulative number of VL cases, C,
dC
dt
= f1γNA, (10)
which is used to fit the model to the data (see below).
In the absence of vector control, the equations for the sandfly infection stages, in terms of proportions of the total
sandfly population NV (t), are:
dS V
dt
= αV (t) − (λV + αV (t))S V , (11)
dEV
dt
= λVS V − (σ + αV (t))EV , (12)
dIV
dt
= σEV − αV (t)IV , (13)
where αV (t) = µV (1 + a1 cos(ωt + a2)), with ω = 2pi/365, is the seasonally-varying sandfly birth rate and
λV =
β(p1A + p2(K1 + K2) + p3(T1 + T2)), for m = 2β(p1A + p2K1 + p3(T1 + T2)), for m = 1 (14)
is the force of infection from humans towards sandflies.
The effect of indoor residual spraying of insecticide (IRS) on the sandfly population is modelled via an increase
in the sandfly death rate following the start of IRS, from µV to (1 + )µV , where  is proportional to the IRS coverage
c with constant of proportionality e (the IRS efficacy factor), i.e.  = ec. The SHR, nV (t), is therefore given by
dnV
dt
=
(αV (t) − µV )nV = µVa1 cos(ωt + a2)nV , for t ≤ tIRS(αV (t) − (1 + )µV )nV = (−µV + µVa1 cos(ωt + a2))nV , for t > tIRS , (15)
where tIRS is the start date of IRS. This can be solved analytically to give
nV (t) =
n∗V exp
(
µV a1
ω
sin(ωt + a2)
)
, for t ≤ tIRS
n∗V exp
(
−µV (t − tIRS ) + µV a1ω sin(ωt + a2)
)
, for t > tIRS ,
(16)
where the constant n∗V = nV (0) exp(− µV a1ω sin(a2)) determines the mean sandfly density. We fit to n∗V rather than the
initial SHR nV (0), as for a given incidence nV (0) varies with the phase shift of the seasonal variation in the sandfly
birth rate a2.
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Table S1. Model parameters: definitions and values used in model fitting
Parameter Definition Value used in model fitting Source
N Number of humans Estimated total population of affected
sub-districts in each district on 1st Jan-
uary 2012∗
[15]
α Human birth rate Set equal to net death rate -
µ Human death rate District-specific (see Table S2) [16]
1/γ Average duration of asymptomatic infec-
tion
150 days [2]
f1 Proportion of asymptomatic individuals
who develop KA
3% Assumed
based on [7]
1/δ Mean time from onset of KA symptoms to
treatment
Erlang distribution fitted to distribution
of times for each district (see Table S3)
CARE data
µK Excess mortality rate due to KA 1/150 day−1 Assumed
1/τ Duration of 1st or 2nd treatment for KA 28 days CARE data
µT Excess mortality rate due to 1st- or 2nd-
line treatment
1/600 day−1 [12, 23]
f2 Proportion of KA patients who have 2nd
treatment
District-specific (see Table S1 in Sup-
plementary File 2 (SF2))
CARE data
1/κ Average duration of immunity 5 yrs Assumed
p1 Relative infectivity of asymptomatic indi-
viduals
0.025 Assumed
based on [22]
p2 Infectivity of individuals with KA 1 Reference
value
p3 Relative infectivity of patients undergoing
1st or 2nd treatment
0.5 Assumed
n∗V Baseline effective sandfly-to-human ratio District-specific Model fitting
a1 Relative amplitude of seasonal variation in
sandfly birth rate
0.3 [5, 13, 18, 19,
24]
a2 Phase shift of seasonal variation in sandfly
birth rate
2pi/3 [5, 10, 18]
1/µV Average sandfly life expectancy 14 days [17]
1/σ Average duration of latent infection in
sandfly
8 days [9, 17, 20]
β Sandfly biting rate 1/4 day−1 [8]
c IRS coverage District-specific (see Table S1 in SF2) CARE data
e IRS efficacy factor 0.006 Parameter
uncertainty
analysis‡
 = ec Proportional increase in sandfly death rate
due to IRS
District-specific -
pH Probability susceptible human becomes in-
fected when bitten by infectious sandfly
1 Reference
value†
∗ Affected sub-districts are those that have ≥1 KA case during the study period (January 2012–June 2013). Population
estimated from annual percentage growth rate between 2001 and 2011.
† pH is inversely correlated with n∗V , hence overestimation of pH is compensated for by underestimation of n
∗
V in model
fitting.
‡ Average of district maximum likelihood estimates for e in parameter uncertainty analysis excluding W. Champaran,
which had a much lower MLE for e than the other districts.
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Figure S2. District onset-to-treatment time distributions in 2012 (histograms) and fitted Erlang distributions (red lines). Fitted parameter values for
Erlang distributions are given in Table S3.
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Table S2. District death rates (from [16]).
District Death rate (per 1000/yr)
Saharsa 7.6
E. Champaran 7.8
Samastipur 6.7
Gopalganj 6.3
Begusarai 6.2
Khagaria 9.3
Patna 5.0
W. Champaran 8.7
Table S3. Parameter values for fitted onset-to-treatment time (OT) distributions.
District Number of KA sub-
compartments, m
Mean OT, 1/δ (days) Standard deviation OT,
1/(δ
√
m) (days)
2012 2013 2012 2013
Saharsa 2 33.3 34.2 23.5 24.1
E. Champaran 2 53.4 44.1 37.8 31.2
Samastipur 2 38.2 34.1 27.0 24.1
Gopalganj 1 47.5 42.8 47.5 42.8
Begusarai 1 21.5 22.6 21.5 22.6
Khagaria 2 36.6 33.2 25.9 23.5
Patna 2 44.9 43.0 31.7 30.4
W. Champaran 1 63.6 60.6 63.6 60.6
3. Model fitting
The data used for the model fitting consisted of the monthly number of onsets of VL symptoms for each of the
8 study districts from January 2012 to June 2013 (inclusive). The model was fitted separately to the data for each
district using maximum likelihood estimation, assuming that the transmission dynamics were in equilibrium prior to
2011 and that IRS started in 2011. The number of VL onsets in month T , MT , was assumed to be Poisson distributed
with rate parameter ηT = CT −CT−1, where CT is the cumulative number of VL onsets at the end of month T predicted
by the model, i.e.
P(MT = mT ) =
ηmTT exp(−ηT )
mT !
. (17)
The full likelihood for each district was taken as the product of the probabilities of the 18 monthly case numbers
{mT }T=1,...,18
L =
18∏
T=1
P(MT = mT ) =
18∏
T=1
ηmTT
mT !
exp
− 18∑
T=1
ηT
 . (18)
The baseline SHR, n∗V , was estimated for each district by maximising the log-likelihood
log L =
18∑
T=1
(mT log ηT − ηT − log(mT !)), (19)
using the interior-point algorithm in the fmincon function in MATLAB (version 8.6). For each evaluation of the
likelihood, the model was run for 200 years prior to the start of the data in 2012 so that the transmission dynamics
reached equilibirum.
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3.1. Calculating R0
A key parameter in the transmission dynamics of an infectious disease is the basic reproduction number, R0, de-
fined for a homogeneously mixing population as the average number of secondary cases caused by a single infectious
case when the population is entirely susceptible and there are no interventions. If R0 > 1, the disease can spread
through the population and a stable endemic equilibrium can be established. If R0 ≤ 1, the only equilibrium is the
stable disease-free equilibrium and the disease will eventually die out.
Since we assume in the model that the population is homogeneously mixed (which is a limitation of the model,
see Discussion in main text), we require R0 > 1 for there to be an endemic equilibrium. However, the incidence of
VL at the district-level is very low, so the range of parameter values for which R0 > 1 and the model gives a good
fit to the district incidences is very small. Thus, for each set of parameter values proposed in the fitting algorithm we
calculate R0 before solving the ODE system (1)–(14) to avoid wasted calculations when R0 ≤ 1.
3.1.1. Without seasonality in sandfly population
For vector-borne diseases, such as VL, R0 depends on the vector-to-host ratio, and a common simplifying assump-
tion is to treat the vector-to-host ratio as constant throughout the year. If this assumption were appropriate for the
Indian subcontinent, i.e. if nV = NV/N ≈ const., we could calculate R0 for the system of equations (1)–(14) by the
standard next generation matrix approach [4] to obtain
R0 =
√
NVβ2 pH
NµV
σ
σ + µV
1
γ + µ
[
p1 + f1γDK (p2 + 2δDK (p2 + 2δDT p3 (1 + f2τDT )))
]
, (20)
for 2 KA sub-compartments, where DK = 1/(2δ + µ + µK) and DT = 1/(τ + µ + µK + µT ) are the mean durations of
the symptomatic stages and first/second treatment (accounting for mortality). From this expression we can see that, in
the absence of seasonality, the SHR NV/N and the asymptomatic infectivity p1 cannot be individually estimated just
from the incidence of symptomatic infection (which determines R0). This expression also suggests that the proportion
of asymptomatic individuals progressing to clinical VL, f1, and the average duration of asymptomatic infection, 1/γ,
are likely to be strongly correlated for a given incidence, so that they cannot be estimated separately from the data;
and that the relative infectivity of individuals under first/second treatment, p3, is also likely to be unidentifiable.
3.1.2. With seasonal variation in sandfly population
The SHR in India is clearly not constant throughout the year, however, as sandflies show marked seasonal variation
in numbers (see references in Table S1 and main text). To account for this it is necessary to extend the definition of
R0 to cater for periodic variation in the sandfly population. We calculate R0 for our model following the approach of
Bacae¨r [1], which is an extension of the next generation matrix method.
First we reduce the system (1)–(14) to equations for just the set of infected states {A,K1,K2,T1,T2, EV , IV } ((2)–(6)
and (12)–(13)), known as the infection subsystem. Then we linearise the infection subsystem about the disease-free
equilibrium (S = 1, S V = 1, A,K1,K2,T1,T2, EV , IV = 0), and write down matrices of the transmissions, T , and
7
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transitions, Σ, associated with the infected states:
T =

0 . . . . . . . . . 0 0 βpHnV (t)
...
. . .
...
... 0
...
. . .
...
...
...
...
. . .
...
...
...
0 . . . . . . . . . 0 0 0
βp1 βp2 βp2 βp3 βp3 0 0
0 . . . . . . . . . . . . 0 0

, (21)
Σ =

γ + µ 0 . . . . . . . . . . . . 0
− f1γ 2δ + µ1 . . .
...
0 −2δ 2δ + µ1 . . .
...
...
. . . −2δ τ + µ2 . . .
...
0 . . . 0 − f2τ τ + µ2 . . .
...
0 . . . . . . . . . 0 σ + αV (t) 0
0 . . . . . . . . . 0 σ αV (t)

(22)
With these definitions we can write the linearised infection subsystem as
dx
dt
= (T (t) − Σ(t))x(t), (23)
where x = (A,K1,K2,T1,T2, EV , IV )T , and T and Σ are matrix-valued periodic functions of t with period p = 365
days. To determine R0 we need to determine the condition for this system to have a non-trivial stable p-periodic
solution (i.e. for there to be a stable endemic equilibrium). It transpires that this condition is equivalent to R0 being
the unique positive root of the equation
ρ(X(p, λ)) = 1, (24)
where ρ is the spectral radius (the largest eigenvalue in absolute value) of the fundamental matrix solution X(t, λ) at
time t = p of
∂
∂t
X(t, λ) =
(
T (t)
λ
− Σ(t)
)
X(t, λ), (25)
X(0) = I7, (26)
where I7 is the 7 × 7 identity matrix (see [1, 4] for details). We therefore calculate R0 by combining a root-finding
algorithm (the trust-region-dogleg algorithm under the fsolve function in MATLAB) with a numerical method
for solving (25)–(26). For each value of λ, X(p, λ) is calculated by solving (25)–(26) over one period with the 7
standard unit vectors of R7 as initial conditions (using the MATLAB solver ode45) and taking the resulting vectors at
t = p as the columns of X.
4. Parameter uncertainty analysis
Due to the lack of data available to accurately quantify many parts of the transmission process, e.g. the durations
of different stages of infection and the infectivity of individuals in these stages to sandflies, there is a large amount of
uncertainty in the values of many of the model parameters. We therefore conducted a parameter uncertainty analysis
to determine the ranges of parameter values for which the model gives a good fit to the data. Nine parameters were
considered: the baseline SHR, n∗V ; the amplitude and phase shift of the seasonal variation in the sandfly birth rate, a1
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and a2; the proportion of asymptomatic individuals who develop clinical VL, f1; the average duration of asymptomatic
infection, 1/γ; the relative infectivities of asymptomatic individuals and individuals undergoing treatment, p1 and p3;
the duration of immunity, 1/κ; and the IRS efficacy factor e. Ninety-five per cent confidence intervals for these
parameters were determined by sampling 300,000 parameter sets from bounded uniform distributions, simulating the
model with these parameter sets and accepting those for which the goodness of fit was close to that for the maximum
likelihood estimates (MLEs) using the likelihood ratio test (i.e. those for which the log-likelihood differed by less
than χ21(0.95)/2 = 1.92 from the maximum log-likelihood, (log LMLE − log L) < χ21(0.95)/2). The upper bound for
the proportion of asymptomatic individuals who develop clinical VL was chosen based on an assumed asymptomatic
infection prevalence of 1% at district level [3], the largest estimated district incidence being approximately 5/10,000/yr
and the longest estimate for the average asymptomatic infection duration in [11] being roughly 530 days, so that,
assuming the transmission dynamics are in equilibrium,
f1,maxγ ≈ [max. VL incidence]Aeqm =
0.0005
0.01
= 0.05/yr
⇒ f1,max = 0.05
γ
=
0.05
365/530
= 0.073.
The lower bound for f1 was chosen as 1% since the lowest estimate from field studies is 3.48% [6] and a value lower
than 1% therefore seems implausible. The lower and upper bounds for the other parameters were chosen to give
relatively broad ranges around the fixed values used in the analysis in the main text and based on plausible bounds
from parameter estimates in the literature. The proposed and accepted ranges for all the parameter values and the
maximum likelihood parameter estimates for each district are shown in Table S4.
The confidence intervals (CIs) for most of the parameters are wide across all the districts indicating that the data
is equally well explained by a large range of parameter values. However, the accepted ranges for the phase shift in
the seasonal forcing of the sandfly birth rate are clearly tighter than the proposed range, apart from for the two least
endemic districts (Patna and West Champaran), covering 1.83–2.72 (corresponding to a peak in the sandfly population
between late October and late November). The maximum likelihood parameter estimates also vary considerably
across districts. The MLEs for the duration of asymptomatic infection range between 98 and 163 days, but are mostly
in the range 110-150 days, which agrees with our previous estimate of 147 days (95% CI 130–166 days) [2], and
together with the peaks in clinical cases in January–April suggests a peak in transmission in August–November (in
the preceding year), coinciding with the seasonal peak in sandfly density.
Figure S3 shows the parameter values for each district for which the model likelihood is close to the maximum
likelihood, specifically, for which the difference in the log-likelihood is less than χ29(0.95)/2 = 8.46, i.e. not significant
by the likelihood ratio test with 9 degrees of freedom at significance level 0.05 (red dots); and parameter values for
which the likelihood is significantly different (blue dots). Below Figure S3 are matrices of the parameter correlation
coefficients (defined for vectors of parameter values X and Y as cov(X,Y)/
√
var(X)var(Y), where cov(X,Y) is the
covariance of X and Y and var(X) is the variance of X, so that 1 represents perfect positive correlation, -1 perfect
negative correlation and 0 no correlation) for the high-likelihood parameter sets (red dots in Figure S3) for each
district. It is clear from the plots and matrices that the baseline SHR n∗V and the relative infectivity of asymptomatic
individuals p1 are strongly negatively correlated (with correlation coefficients ranging between -0.89 and -0.56 for
the different districts), as might be expected from the expression for R0 without seasonality (20). The amplitude of
the seasonal forcing of the sandfly birth rate a1 and the mean duration of asymptomatic infection 1/γ are positively
correlated for most districts. This is because a longer asymptomatic duration (larger 1/γ) dampens the seasonality in
VL incidence caused by seasonality in the sandfly birth rate, which can be compensated for by a greater amplitude
in the seasonal variation in the birth rate (greater a1). The IRS efficacy e and 1/γ are also positively correlated
for most districts, as a greater reduction in sandfly density due to a higher IRS efficacy can counterbalance more
transmission from asymptomatic individuals due to a longer asymptomatic duration to give similar VL incidence.
These observations imply that n∗V , p1, a1, 1/γ and e cannot be uniquely determined from the data. Thus the district-
level estimates for n∗V in the main paper should be viewed as relative estimates, as they are only unique up to the
choice of values for p1 and a1 (in addition to being underestimates due to choosing pH = 1). The wide CIs and
even distribution of points in the scatter plots for the mean duration of immunity, 1/κ, show that there is insufficient
information in the data to estimate this parameter with any precision. In the simulations in the main text we therefore
assume a value of 5 years for 1/κ, and discuss issues related to the unknown duration of immunity in the Discussion.
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Figure S4 shows the predicted VL incidence for each district with the parameter MLEs and continuation of existing
interventions. Table S5 gives the MLE and 95% CI for the elimination month for each district, defined as the month
in which the incidence decreases below 1/10,000/yr and thereafter stays below this level. Confidence intervals were
determined by taking the minimum and maximum predicted incidence at each time point across the model outputs for
all the accepted parameter sets. The MLEs for the elimination month span from April 2013 for Begusarai to March
2016 for Saharsa, and agree well with those from the model fitting in the main text. All the confidence intervals for
the elimination month span 1–2 years, except those for E. Champaran (April 2013–May 2013) and Khagaria (March
2014–March 2018). The narrow confidence interval for E. Champaran likely reflects the strong seasonal pattern in its
monthly numbers of VL cases (see Figure S1 in Supplementary File 2), which can only be reproduced by small ranges
of parameter values. Conversely, the very wide confidence interval for Khagaria reflects the lack of a clear seasonal
pattern in its VL case numbers, which can be generated by large ranges of parameter values.
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Table S4. Parameter uncertainty analysis: proposed and accepted ranges for parameter values and maximum likelihood estimates for each district. Sh = Saharsa, EC = East Champaran, Sm =
Samastipur, G = Gopalganj, B = Begusarai, K = Khagaria, P = Patna, WC = West Champaran.
Parameter Proposed
range∗
Accepted range† Maximum likelihood estimate
Sh EC Sm G B K P WC Sh EC Sm G B K P WC
Sandfly-to-human ratio, n∗V 0.1–0.6 0.14–0.59 0.11–0.54 0.31–0.47 0.14–0.46 0.10–0.59 0.10–0.60 0.10–0.59 0.13–0.60 0.34 0.27 0.46 0.35 0.59 0.17 0.36 0.35
Seasonal forcing amplitude,
a1
0.1–0.5 0.19–0.50 0.32–0.50 0.31–0.35 0.29–0.45 0.15–0.49 0.23–0.46 0.10–0.47 0.10–0.33 0.29 0.37 0.34 0.34 0.24 0.40 0.12 0.14
Seasonal phase shift, a2 7pi12 –pi 1.90–2.28 2.27–2.65 1.87–1.91 1.84–1.95 1.83–2.39 2.07–2.72 1.83–3.05 1.85–2.98 2.11 2.42 1.88 1.88 1.97 2.43 2.33 2.52
Fraction of asymptomatic in-
dividuals who develop VL, f1
0.01–0.073 0.010–0.073 0.010–0.063 0.022–0.063 0.013–0.063 0.011–0.068 0.010–0.071 0.010–0.072 0.010–0.063 0.013 0.019 0.022 0.027 0.028 0.020 0.013 0.043
Average duration of asymp-
tomatic infection, 1/γ (days)
90–180 115–180 98–153 97–118 92–169 95–177 102–176 92–179 93–177 163 109 116 117 98 141 123 122
Relative infectivity of asymp-
tomatic individuals, p1
0.01–0.07 0.013–0.067 0.015–0.065 0.015–0.020 0.017–0.049 0.011–0.068 0.012–0.068 0.010–0.070 0.011–0.070 0.030 0.035 0.015 0.021 0.016 0.044 0.034 0.018
Relative infectivity of patients
under treatments 1 and 2, p3
0.1–1 0.14–1.00 0.12–0.97 0.61–0.91 0.26–0.97 0.10–1.00 0.14–0.96 0.10–0.99 0.14–1.00 0.58 0.84 0.91 0.83 0.98 0.22 0.64 0.95
Average duration of immunity,
1/κ (yrs)
3–8 3.5–8.0 3.2–7.9 4.4–6.5 3.2–7.9 3.3–8.0 3.0–7.9 3.0–8.0 3.1–7.9 4.5 6.8 6.4 5.5 5.1 4.2 4.1 6.8
IRS efficacy factor, e 0–0.015 0.003–0.008 0.008–0.014 0.003–0.004 0.003–0.008 0.003–0.010 0.001–0.006 0.003–0.015 0.0001–0.007 0.005 0.008 0.003 0.005 0.005 0.003 0.010 0.0004
∗ Simulations run with 300,000 parameter sets sampled from random uniform distributions over proposed parameter ranges
† Parameter sets accepted if model log-likelihood (19) was within χ21(0.95)/2 = 1.92 of maximum log-likelihood over all simulations.
Figure S3. Parameter uncertainty analysis: scatter matrix plots of the proposed parameter values for each district for which R0 > 1 (blue dots)
and the parameter sets for which the model log-likelihood was within χ29(0.95)/2 = 8.46 of the maximum log-likelihood (red dots). Marginal
distributions of proposed parameters (blue histograms) and parameters for which the model likelihood was not significantly different from the
maximum likelihood (red histograms) shown on the main diagonal. Parameters considered: baseline sandfly-to-human ratio n∗V , amplitude and
phase shift of seasonal forcing in sandfly birth rate a1 and a2, proportion of asymptomatic individuals who develop clinical VL f1, mean duration
of asymptomatic infection 1/γ, relative infectivities of asymptomatic individuals and individuals undergoing treatment p1 and p3, mean duration
of immunity 1/κ, and IRS efficacy factor e. Each blue dot represents one of 10,000 simulations (300,000 simulations were run for each district).
Matrices of the parameter correlation coefficients for each district are presented below.
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Saharsa:
n∗V a1 a2 f1 1/γ p1 p3 1/κ e
n∗V 1.00 -0.27 0.03 -0.25 -0.19 -0.56 0.04 0.07 0.01
a1 -0.27 1.00 -0.24 -0.11 0.50 -0.27 -0.02 -0.14 0.32
a2 0.03 -0.24 1.00 0.22 -0.22 0.16 0.02 0.29 0.04
f1 -0.25 -0.11 0.22 1.00 -0.35 -0.01 -0.11 0.38 -0.10
1/γ -0.19 0.50 -0.22 -0.35 1.00 -0.35 0.02 -0.32 0.31
p1 -0.56 -0.27 0.16 -0.01 -0.35 1.00 -0.04 0.24 -0.02
p3 0.04 -0.02 0.02 -0.11 0.02 -0.04 1.00 -0.01 -0.01
1/κ 0.07 -0.14 0.29 0.38 -0.32 0.24 -0.01 1.00 0.09
e 0.01 0.32 0.04 -0.10 0.31 -0.02 -0.01 0.09 1.00
E. Champaran:
n∗V a1 a2 f1 1/γ p1 p3 1/κ e
n∗V 1.00 -0.34 -0.11 -0.32 -0.21 -0.70 0.00 0.07 -0.02
a1 -0.34 1.00 -0.06 -0.02 0.45 -0.14 -0.02 0.07 0.25
a2 -0.11 -0.06 1.00 0.29 0.26 0.03 -0.36 -0.15 0.27
f1 -0.32 -0.02 0.29 1.00 0.17 -0.02 -0.34 -0.25 0.39
1/γ -0.21 0.45 0.26 0.17 1.00 -0.13 -0.39 -0.29 0.61
p1 -0.70 -0.14 0.03 -0.02 -0.13 1.00 -0.03 -0.10 -0.20
p3 0.00 -0.02 -0.36 -0.34 -0.39 -0.03 1.00 0.37 -0.47
1/κ 0.07 0.07 -0.15 -0.25 -0.29 -0.10 0.37 1.00 -0.39
e -0.02 0.25 0.27 0.39 0.61 -0.20 -0.47 -0.39 1.00
Samastipur:
n∗V a1 a2 f1 1/γ p1 p3 1/κ e
n∗V 1.00 -0.12 -0.51 -0.24 -0.53 -0.89 0.54 0.30 -0.41
a1 -0.12 1.00 -0.01 -0.02 0.23 -0.16 0.15 0.10 0.18
a2 -0.51 -0.01 1.00 -0.09 0.30 0.51 -0.49 -0.39 0.21
f1 -0.24 -0.02 -0.09 1.00 -0.06 0.02 -0.27 -0.13 -0.14
1/γ -0.53 0.23 0.30 -0.06 1.00 0.29 -0.07 -0.16 0.60
p1 -0.89 -0.16 0.51 0.02 0.29 1.00 -0.52 -0.31 0.30
p3 0.54 0.15 -0.49 -0.27 -0.07 -0.52 1.00 0.32 -0.14
1/κ 0.30 0.10 -0.39 -0.13 -0.16 -0.31 0.32 1.00 -0.02
e -0.41 0.18 0.21 -0.14 0.60 0.30 -0.14 -0.02 1.00
Gopalganj:
n∗V a1 a2 f1 1/γ p1 p3 1/κ e
n∗V 1.00 -0.28 -0.29 -0.37 -0.44 -0.76 0.33 -0.18 -0.13
a1 -0.28 1.00 0.03 -0.04 0.39 -0.15 -0.02 0.12 0.28
a2 -0.29 0.03 1.00 0.07 0.35 0.33 -0.49 0.19 0.10
f1 -0.37 -0.04 0.07 1.00 -0.05 0.11 -0.15 0.16 0.02
1/γ -0.44 0.39 0.35 -0.05 1.00 0.11 -0.22 0.18 0.20
p1 -0.76 -0.15 0.33 0.11 0.11 1.00 -0.41 0.12 0.06
p3 0.33 -0.02 -0.49 -0.15 -0.22 -0.41 1.00 -0.14 -0.22
1/κ -0.18 0.12 0.19 0.16 0.18 0.12 -0.14 1.00 0.17
e -0.13 0.28 0.10 0.02 0.20 0.06 -0.22 0.17 1.00
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Begusarai:
n∗V a1 a2 f1 1/γ p1 p3 1/κ e
n∗V 1.00 -0.32 -0.46 -0.18 -0.71 -0.83 0.63 -0.30 -0.39
a1 -0.32 1.00 0.02 -0.02 0.25 0.01 -0.14 0.04 0.18
a2 -0.46 0.02 1.00 0.08 0.46 0.33 -0.41 0.17 0.16
f1 -0.18 -0.02 0.08 1.00 0.08 0.01 -0.09 0.06 0.02
1/γ -0.71 0.25 0.46 0.08 1.00 0.38 -0.59 0.23 0.47
p1 -0.83 0.01 0.33 0.01 0.38 1.00 -0.50 0.26 0.24
p3 0.63 -0.14 -0.41 -0.09 -0.59 -0.50 1.00 -0.24 -0.34
1/κ -0.30 0.04 0.17 0.06 0.23 0.26 -0.24 1.00 0.18
e -0.39 0.18 0.16 0.02 0.47 0.24 -0.34 0.18 1.00
Khagaria:
n∗V a1 a2 f1 1/γ p1 p3 1/κ e
n∗V 1.00 -0.45 0.00 -0.03 -0.19 -0.76 0.28 0.30 0.19
a1 -0.45 1.00 -0.11 -0.25 0.09 0.07 -0.37 -0.34 -0.10
a2 0.00 -0.11 1.00 -0.02 0.02 0.08 -0.04 0.04 -0.03
f1 -0.03 -0.25 -0.02 1.00 -0.06 -0.16 0.20 0.23 0.18
1/γ -0.19 0.09 0.02 -0.06 1.00 -0.12 -0.03 -0.08 0.18
p1 -0.76 0.07 0.08 -0.16 -0.12 1.00 -0.20 -0.15 -0.24
p3 0.28 -0.37 -0.04 0.20 -0.03 -0.20 1.00 0.39 0.34
1/κ 0.30 -0.34 0.04 0.23 -0.08 -0.15 0.39 1.00 0.27
e 0.19 -0.10 -0.03 0.18 0.18 -0.24 0.34 0.27 1.00
Patna:
n∗V a1 a2 f1 1/γ p1 p3 1/κ e
n∗V 1.00 -0.40 -0.01 -0.43 -0.31 -0.71 0.12 -0.26 -0.00
a1 -0.40 1.00 0.02 0.31 0.38 -0.08 -0.20 0.42 -0.02
a2 -0.01 0.02 1.00 0.19 0.14 -0.09 -0.12 0.19 -0.10
f1 -0.43 0.31 0.19 1.00 0.18 -0.00 -0.15 0.39 -0.09
1/γ -0.31 0.38 0.14 0.18 1.00 -0.14 -0.12 0.27 -0.03
p1 -0.71 -0.08 -0.09 -0.00 -0.14 1.00 -0.08 0.02 -0.03
p3 0.12 -0.20 -0.12 -0.15 -0.12 -0.08 1.00 -0.17 0.10
1/κ -0.26 0.42 0.19 0.39 0.27 0.02 -0.17 1.00 -0.11
e -0.00 -0.02 -0.10 -0.09 -0.03 -0.03 0.10 -0.11 1.00
W. Champaran:
n∗V a1 a2 f1 1/γ p1 p3 1/κ e
n∗V 1.00 -0.31 0.08 -0.13 -0.26 -0.79 0.18 0.10 -0.29
a1 -0.31 1.00 -0.07 -0.31 0.22 0.10 -0.36 -0.25 0.33
a2 0.08 -0.07 1.00 0.07 0.00 -0.10 0.09 0.09 -0.08
f1 -0.13 -0.31 0.07 1.00 -0.26 -0.16 0.28 0.21 -0.20
1/γ -0.26 0.22 0.00 -0.26 1.00 0.12 -0.28 -0.17 0.39
p1 -0.79 0.10 -0.10 -0.16 0.12 1.00 -0.28 -0.11 0.32
p3 0.18 -0.36 0.09 0.28 -0.28 -0.28 1.00 0.24 -0.42
1/κ 0.10 -0.25 0.09 0.21 -0.17 -0.11 0.24 1.00 -0.22
e -0.29 0.33 -0.08 -0.20 0.39 0.32 -0.42 -0.22 1.00
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Figure S4. Maximum likelihood estimates (MLE) and 95% confidence intervals (CIs) for predicted VL incidence for each district up to 2020 from
parameter uncertainty analysis
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Table S5. Maximum likelihood estimates (MLEs) of elimination month for each district with 95% confidence intervals (CI) and corresponding
negative log-likelihoods. Elimination month defined as the month in which incidence decreased below 1/10,000/yr and then remained below this
level.
District min(− log L) MLE for elimination month 95% CI for elimination
month
Saharsa 72.3 Mar 2016 Jun 2015 - Jul 2016
E. Champaran 82.3 May 2013 Apr 2013 - May 2013
Samastipur 67.6 Apr 2014 Jun 2013 - May 2014
Gopalganj 59.9 Jun 2014 May 2014 - May 2015
Begusarai 53.6 Apr 2013 May 2012 - May 2013
Khagaria 64.5 Mar 2015 Mar 2014 - Mar 2018
Patna 47.8 ∗ ∗
W. Champaran 42.2 ∗ ∗
∗ Incidence was already <1/10,000/yr in these districts in 2012.
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